Skip to main content

Table 2 Results of whole-body bone SPECT/CT and FCH PET/CT for the different sites evaluated

From: Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?

Relapse site
N (%)
Bone Lymph node Local Total
Positive Negative Equivocal Positive Positive Positive
Bone SPECT/CT 27 (23.5%) 81 (70.5%) 7 (6%) / / 27 (23.5%)
FCH PET/CT 28 (24%) 85 (74%) 2 (1.5%) 45 (41.5%) 35 (32%) 85 (74%)
BVC 30 (26%) 85 (74%) 0 (0%)